Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(1):10–17. doi: 10.1155/S1064744997000057

Double-Blind Placebo-Controlled Treatment Trial of Chlamydia trachomatis Endocervical Infections in Pregnant Women

David H Martin 1, David A Eschenbach 2, Mary Frances Cotch 3, Robert P Nugent 4,10,✉, A Vijaya Rao 5, Mark A Klebanoff 4, Yu Lou 5, Philip J Rettig 6, Ronald S Gibbs 7,9, Joseph G Pastorek II 1, Joan A Regan 8, Richard A Kaslow 3
PMCID: PMC2364533  PMID: 18476128

Abstract

Objective: The purpose of this study was to determine if treatment of pregnant women with Chlamydia trachomatis infection would lower the incidence of preterm delivery and/or low birth weight.

Methods: Pregnant women between the 23rd and 29th weeks of gestation were randomized in double-blind fashion to receive either erythromycin 333 mg three times daily or an identical placebo. The trial continued until the end of the 35th week of gestation.

Results: When the results were examined without regard to study site, erythromycin had little impact on reducing low birth weight (8% vs. 11%, P = 0.4) or preterm delivery (13% vs. 15%, P = 0.7). At the sites with high persistence of C. trachomatis in the placebo-treated women, low birth weight infants occurred in 9 (8%) of 114 erythromycin-treated and 18 (17%) of 105 placebo-treated women (P = 0.04) and delivery <37 weeks occurred in 15 (13%) of 115 erythromycin-treated and 18 (17%) of 105 placebo-treated women (P = 0.4).

Conclusions: The results of this trial suggest that the risk of low birth weight can be decreased by giving erythromycin to some women with C. trachomatis. Due to the high clearance rate of C. trachomatis in the placebo group, these data do not provide unequivocal evidence that erythromycin use in all C. trachomatis-infected women prevents low birth weight.

Full Text

The Full Text of this article is available as a PDF (737.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alger L. S., Lovchik J. C. Comparative efficacy of clindamycin versus erythromycin in eradication of antenatal Chlamydia trachomatis. Am J Obstet Gynecol. 1991 Aug;165(2):375–381. doi: 10.1016/0002-9378(91)90097-b. [DOI] [PubMed] [Google Scholar]
  2. Alger L. S., Lovchik J. C., Hebel J. R., Blackmon L. R., Crenshaw M. C. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol. 1988 Aug;159(2):397–404. doi: 10.1016/s0002-9378(88)80093-0. [DOI] [PubMed] [Google Scholar]
  3. Berman S. M., Harrison H. R., Boyce W. T., Haffner W. J., Lewis M., Arthur J. B. Low birth weight, prematurity, and postpartum endometritis. Association with prenatal cervical Mycoplasma hominis and Chlamydia trachomatis infections. JAMA. 1987 Mar 6;257(9):1189–1194. [PubMed] [Google Scholar]
  4. Blackwelder W. C., Hastings B. K., Lee M. L., Deloria M. A. Value of a run-in period in a drug trial during pregnancy. Control Clin Trials. 1990 Jun;11(3):187–198. doi: 10.1016/0197-2456(90)90013-r. [DOI] [PubMed] [Google Scholar]
  5. Cohen I., Veille J. C., Calkins B. M. Improved pregnancy outcome following successful treatment of chlamydial infection. JAMA. 1990 Jun 20;263(23):3160–3163. [PubMed] [Google Scholar]
  6. Crombleholme W. R., Schachter J., Grossman M., Landers D. V., Sweet R. L. Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol. 1990 May;75(5):752–756. [PubMed] [Google Scholar]
  7. Eagar R. M., Beach R. K., Davidson A. J., Judson F. N. Epidemiologic and clinical factors of Chlamydia trachomatis in black, Hispanic and white female adolescents. West J Med. 1985 Jul;143(1):37–41. [PMC free article] [PubMed] [Google Scholar]
  8. Eschenbach D. A., Nugent R. P., Rao A. V., Cotch M. F., Gibbs R. S., Lipscomb K. A., Martin D. H., Pastorek J. G., Rettig P. J., Carey J. C. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1991 Mar;164(3):734–742. doi: 10.1016/0002-9378(91)90506-m. [DOI] [PubMed] [Google Scholar]
  9. Gravett M. G., Nelson H. P., DeRouen T., Critchlow C., Eschenbach D. A., Holmes K. K. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA. 1986 Oct 10;256(14):1899–1903. [PubMed] [Google Scholar]
  10. Handsfield H. H., Murphy V. L. Treatment of uncomplicated gonorrhea in women with single-dose cefonicid. Sex Transm Dis. 1985 Apr-Jun;12(2):90–92. doi: 10.1097/00007435-198504000-00008. [DOI] [PubMed] [Google Scholar]
  11. Harrison H. R., Alexander E. R., Weinstein L., Lewis M., Nash M., Sim D. A. Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA. 1983 Oct 7;250(13):1721–1727. [PubMed] [Google Scholar]
  12. Heggie A. D., Lumicao G. G., Stuart L. A., Gyves M. T. Chlamydia trachomatis infection in mothers and infants. A prospective study. Am J Dis Child. 1981 Jun;135(6):507–511. doi: 10.1001/archpedi.1981.02130300007005. [DOI] [PubMed] [Google Scholar]
  13. Klebanoff M. A., Regan J. A., Rao A. V., Nugent R. P., Blackwelder W. C., Eschenbach D. A., Pastorek J. G., 2nd, Williams S., Gibbs R. S., Carey J. C. Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol. 1995 May;172(5):1540–1545. doi: 10.1016/0002-9378(95)90493-x. [DOI] [PubMed] [Google Scholar]
  14. Linnemann C. C., Jr, Heaton C. L., Ritchey M. Treatment of Chlamydia trachomatis infections: comparison of 1- and 2-g doses of erythromycin daily for seven days. Sex Transm Dis. 1987 Apr-Jun;14(2):102–106. [PubMed] [Google Scholar]
  15. Martin D. H., Koutsky L., Eschenbach D. A., Daling J. R., Alexander E. R., Benedetti J. K., Holmes K. K. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA. 1982 Mar 19;247(11):1585–1588. [PubMed] [Google Scholar]
  16. McCormack W. M., Rosner B., Lee Y. H., Munoz A., Charles D., Kass E. H. Effect on birth weight of erythromycin treatment of pregnant women. Obstet Gynecol. 1987 Feb;69(2):202–207. [PubMed] [Google Scholar]
  17. Plummer F. A., Laga M., Brunham R. C., Piot P., Ronald A. R., Bhullar V., Mati J. Y., Ndinya-Achola J. O., Cheang M., Nsanze H. Postpartum upper genital tract infections in Nairobi, Kenya: epidemiology, etiology, and risk factors. J Infect Dis. 1987 Jul;156(1):92–98. doi: 10.1093/infdis/156.1.92. [DOI] [PubMed] [Google Scholar]
  18. Ryan G. M., Jr, Abdella T. N., McNeeley S. G., Baselski V. S., Drummond D. E. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol. 1990 Jan;162(1):34–39. doi: 10.1016/0002-9378(90)90815-o. [DOI] [PubMed] [Google Scholar]
  19. Schachter J., Grossman M., Sweet R. L., Holt J., Jordan C., Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA. 1986 Jun 27;255(24):3374–3377. [PubMed] [Google Scholar]
  20. Schachter J., Sweet R. L., Grossman M., Landers D., Robbie M., Bishop E. Experience with the routine use of erythromycin for chlamydial infections in pregnancy. N Engl J Med. 1986 Jan 30;314(5):276–279. doi: 10.1056/NEJM198601303140503. [DOI] [PubMed] [Google Scholar]
  21. Stamm W. E., Tam M., Koester M., Cles L. Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol. 1983 Apr;17(4):666–668. doi: 10.1128/jcm.17.4.666-668.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sweet R. L., Landers D. V., Walker C., Schachter J. Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol. 1987 Apr;156(4):824–833. doi: 10.1016/0002-9378(87)90338-3. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES